hrHPV positivity in ASC-US Papanicolaou tests from women with treated HPV- and non-HPV-related gynecologic malignancies

This publication has 9 references indexed in Scilit:

• Cervical Cancer, Version 2.2015
  Journal of the National Comprehensive Cancer Network, 2015
• Clinical Performance of Hybrid Capture 2 Human Papillomavirus Testing for Recurrent High-Grade Cervical/Vaginal Intraepithelial Neoplasm in Patients With an ASC-US Papanicolaou Test Result During Long-Term Posttherapy Follow-up Monitoring
  Archives of Pathology & Laboratory Medicine, 2015
• Age‐stratified 5‐year risks of cervical precancer among women with enrollment and newly detectedHPVinfection
  International Journal of Cancer, 2014
• Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS
  Journal of Lower Genital Tract Disease, 2013
• Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results
  Journal of Lower Genital Tract Disease, 2013
• Cervicovaginal Cytology in the Detection of Recurrence After Cervical Cancer Treatment
  Obstetrics & Gynecology, 2011
• Follow-up for women after treatment for cervical cancer: A systematic review
  Gynecologic Oncology, 2009
• Significance of High-Risk Human Papillomavirus DNA–Positive Atypical Squamous Cells of Undetermined Significance Pap Smears in Perimenopausal and Postmenopausal Women
  Acta Cytologica, 2008
• Cytologic diagnosis of atypical squamous cells of undetermined significance in perimenopausal and postmenopausal women
  Cancer, 2007